logo
REACH OUT TO US +91 82830 85118 +91 91157 96473 contact@gspharma.tech

Formulation Research & Development

Comprehensive Formulation Capabilities

Dosage Form Development

Globesynth Pharma Tech offers extensive experience across a broad spectrum of dosage forms, tailored to both innovator and generic pharmaceutical programs:

Oral Solid Dosage Forms
  • Immediate-release (IR), modified-release (MR), sustained-release (SR), and delayed-release (DR) tablets
  • Film-coated, enteric-coated, and multilayer tablets
  • Hard gelatin and HPMC capsules
  • Multiparticulate systems (pellets, granules, MUPS)
Liquid Dosage Forms:
  • Oral solutions, suspensions, emulsions, and syrups
  • Pediatric and geriatric-friendly formulations
  • Preservative and solvent optimization for safety and stability
Semi-Solid Dosage Forms:
  • Topical creams, ointments, gels, and lotions
  • Dermatological and transdermal applications
Parenteral & Sterile Products:
  • Injectable formulations (aqueous and non-aqueous)
  • Lyophilized (freeze-dried) products
  • Sterile filtration and aseptic process compatibility studies
Specialized Dosage Forms:
  • Sublingual and buccal formulations
  • Orally disintegrating tablets (ODTs) and films (ODFs)
  • Fixed-dose combinations (FDCs)
Advanced Drug Delivery & Enabling Technologies

We apply innovative drug delivery approaches to overcome formulation challenges and enhance therapeutic performance:

  • Controlled and modified-release technologies
  • Bioavailability enhancement for poorly soluble and BCS Class II/IV drugs
  • Particle size reduction and nano-formulation strategies
  • Lipid-based and solubility-enhancing systems
  • Taste masking technologies to improve patient compliance
  • Excipient selection aligned with regulatory acceptability
Pre-Formulation & Analytical Development Support

A strong analytical foundation ensures scientifically robust and regulator-ready formulation development:

Pre-Formulation Studies
  • API physicochemical characterization
  • Solubility and pH profiling
  • Solid-state characterization and polymorphism studies
  • Particle size distribution and flow property evaluation
  • Hygroscopicity and thermal behavior studies
Analytical Development
  • Development of stability-indicating analytical methods
  • Method validation as per ICH guidelines
  • Dissolution method development and optimization
  • Impurity profiling and degradation pathway evaluation
  • Support for extractables and leachables assessments (as applicable)
Formulation Design & Optimization
Prototype Development
  • Rational formulation design using Quality by Design (QbD)
  • Application of Design of Experiments (DoE) for formulation optimization
  • Excipient screening and risk assessment
  • Rapid development of clinical trial and pilot formulations
Process Optimization
  • Selection of suitable manufacturing processes:
    • Direct compression
    • Wet and dry granulation
    • Roller compaction
    • Coating technologies
  • Identification and control of Critical Quality Attributes (CQAs) and Critical Process Parameters (CPPs)
Scale-Up, Technology Transfer & Manufacturing Readiness
  • Laboratory-to-pilot-scale development
  • Pilot-scale batch manufacturing support
  • Technology transfer packages for commercial manufacturing
  • Process validation support and continued process verification
  • Coordination with third-party GMP-compliant manufacturing facilities
Stability & Lifecycle Management
  • ICH-compliant stability studies (accelerated, intermediate, long-term)
  • Photostability and stress studies
  • Shelf-life estimation and storage condition recommendations
  • Support for post-approval changes and lifecycle management
Bioavailability & Bioequivalence Support
  • Formulation optimization for enhanced in-vivo performance
  • Comparative dissolution and similarity factor (f2) studies
  • Support for BA/BE studies for generic development
  • IVIVC support where applicable
Regulatory Strategy & Documentation

Globesynth Pharma Tech ensures that all formulation programs are regulatory-ready and aligned with global submission standards:

  • Preparation of CTD Modules 2 & 3
  • ANDA, NDA, and lifecycle management submissions
  • Compliance with ICH, US FDA, EMA, MHRA, and other global agencies
  • Regulatory responses and deficiency support
Client-Focused Engagement Models
  • Flexible engagement models (project-based or dedicated teams)
  • Confidentiality and IP protection
  • Transparent communication and milestone-driven execution
  • Customized solutions aligned with client timelines and budgets

Why Globesynth Pharma Tech for Formulation R&D?

  • Integrated formulation, analytical, and regulatory expertise
  • Proven experience with complex APIs and challenging formulations
  • Strong quality systems and compliance culture
  • Scalable solutions from early development to commercialization
  • Reliable, confidential, and science-driven partner